Key Moments

359 ‒ How metabolic and immune system dysfunction drive the aging process, NAD, aging clocks, & more

Peter Attia MDPeter Attia MD
Science & Technology3 min read152 min video
Aug 4, 2025|86,239 views|1,574|131
Save to Pod
TL;DR

Metabolism and immune health are key to aging, with focus on fuel utilization, NAD+ decline, and immune system aging.

Key Insights

1

The immune system and central nervous system are rate-limiting organs for aging.

2

Metabolism, particularly fuel utilization (ketones, fatty acids, glucose), significantly impacts aging.

3

Oxidative stress, while complex, remains a factor in aging, with antioxidants having nuanced effects.

4

NAD+ levels decline with age, impacting sirtuin activity and overall metabolism; its supplementation is complex.

5

The aging immune system shows reduced vaccine response and increased susceptibility to infections, with thymic shrinkage playing a role.

6

Biomarkers and 'aging clocks' are emerging tools but require further validation for clinical use.

THE CENTRAL ROLE OF THE IMMUNE AND NERVOUS SYSTEMS

The conversation highlights the immune system and the central nervous system as two crucial organs that are rate-limiting in the aging process. Their distributed nature means their function impacts the entire organism. Research indicates that biomarkers measuring aging in these organs are highly predictive of lifespan. Furthermore, studies in mice suggest that impairing the immune system, even through specific genetic mutations affecting DNA repair or mitochondrial function, can accelerate aging across the entire organism, underscoring the immune system's profound influence on systemic aging.

METABOLISM AND FUEL UTILIZATION IN AGING

Metabolism is a cornerstone of aging, with a particular emphasis on fuel utilization. The efficiency with which our bodies burn different substrates—ketones, fatty acids, glucose, and lactate—plays a significant role. Ketones are considered the cleanest fuel, generating fewer byproducts and less oxidative stress. Conversely, glucose, especially rapidly absorbed forms leading to high insulin spikes, is associated with greater metabolic burden and is linked to interventions that have shown lifespan benefits in studies like the ITP.

THE NUANCES OF OXIDATIVE STRESS AND AGING

While the theory that oxidative stress is a primary driver of aging has faced challenges, its role remains significant. The process of energy production in mitochondria inherently leaks electrons, which react with oxygen to form reactive oxygen species (ROS). While ROS can be damaging, they also serve signaling roles, particularly during exercise. The failure of broad-spectrum antioxidants in trials suggests that a targeted approach is needed, rather than general suppression, as ROS can have beneficial as well as detrimental effects depending on the context.

NAD+ METABOLISM, SIRTUINS, AND AGING

Nicotinamide adenine dinucleotide (NAD+) is a critical coenzyme for numerous metabolic reactions and DNA repair via sirtuins. NAD+ levels decline significantly with age, impacting enzyme activity and metabolic efficiency. While supplementation with NAD+ precursors like NMN and NR is popular, it's complex. Production and degradation pathways, involving enzymes like CD38 and PARPs, are crucial. Research suggests that elevated CD38 activity drives NAD+ depletion, and while NMN/NR supplementation can increase NAD+ levels, potential side effects like elevated homocysteine and increased production of pro-inflammatory SASP factors warrant caution and further study.

IMMUNE SYSTEM AGING AND INFECTION SUSCEPTIBILITY

Aging significantly impairs immune function, a phenomenon termed 'immunosenescence'. This decline is linked to thymic involution, where the thymus shrinks and is replaced by fat, reducing the output of naive T-cells crucial for adaptive immunity. Consequently, older adults experience reduced vaccine efficacy and are more vulnerable to infections, as tragically highlighted during the COVID-19 pandemic. While the adaptive immune system develops memory, its ability to mount a robust response diminishes with age.

BIOMARKERS, AGING CLOCKS, AND FUTURE DIRECTIONS

The field of aging research is increasingly utilizing biomarkers and epigenetic clocks to assess biological age. While promising, these tools are still largely research-based and require significant validation before clinical use. Challenges include biological variability, the tenuous link between methylation sites and specific biological functions, and the potential for confounding factors like immune cell composition or pharmaceutical interventions. Emerging approaches, such as proteomic and organ-specific clocks, aim to provide more comprehensive and clinically relevant insights into an individual's aging trajectory.

Common Questions

The central nervous system and the immune system are considered rate-limiting organs for aging. This is because both are distributed throughout the organism, and their systemic activity can influence the functioning of every other organ.

Topics

Mentioned in this video

People
Martin Brand

A colleague of Eric's at the Buck Institute and a leader in bioenergetics, who identified sites of reactive oxygen species generation and developed specific inhibitors.

Ralph DeFronzo

A world's authority on the gut's role in metabolism and GLP-1's role in beta cell activity.

Dan Belsky

Developer of the 'Dunedin Pace' epigenetic clock, which measures the rate of aging and appears to respond to interventions.

Morgan Levine

Researcher who, along with others like Dan Belsky, has contributed to the development of epigenetic aging clocks.

Matt Camberlin

Famously purchased and tested multiple commercially available aging clocks, finding significant disagreement between and within them. Also discussed his expertise on rapamycin.

Eduardo Chini

First to show that CD38 is the major driver of NAD+ decrease during aging, publishing that CD38 knockout mice do not experience this decline and live longer.

Mike McHugh

Colleague of Eric's at the Gladstone Institute, whose work on HIV patients inspired a trial for thymic regeneration using human growth hormone.

Lenny Guarente

Published a paper on sirtuins in yeast, paving the way for further research into sirtuins and NAD+.

Rich Miller

Speaker mentioned that Rich Miller has been a guest on the podcast several times, likely discussing the ITP.

Mark Davis

A collaborator at Stanford on the 10,000 Immunome Project, who co-developed 'I age' and studies aging in the human immune system.

Steve Austad

Coined the 'longevity quotient' concept, which highlights the correlation between animal size and lifespan.

More from Peter Attia MD

View all 333 summaries

Found this useful? Build your knowledge library

Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.

Get Started Free